Dynavax Technologies Corp is a biopharmaceutical company based in Emeryville, California, specializing in the development and commercialization of vaccines. Its flagship product is HEPLISAV-B, a hepatitis B vaccine designed for adults, which is available in the United States and Europe. The company also produces CpG 1018, a key ingredient in HEPLISAV-B. Dynavax collaborates with several global partners to expand its vaccine offerings and improve public health outcomes.
In the past week or so, a couple of initial public offerings prompted huge insider buying. However, these were not the only notable insider purchases recently.
Market pullbacks can make nervous investors leery of investing in industries that are more speculative. Wall Street still has big expectations for Vir Biotechnology.
Wednesday's top analyst upgrades and downgrades included Altice USA, Boeing, Dynavax, EnLink Midstream, FedEx, Hasbro, Meta Platforms, Micron Technology, Snap and TransDigm.
Friday's top analyst upgrades and downgrades included CenterPoint Energy, Cloudflare, Dynavax Technologies, HCA Healthcare, Opendoor Technologies, Roku, Salesforce.com, Spotify Technology and Wheaton Precious Metals.
Tuesday afternoon's top analyst upgrades and downgrades included Amazon.com, Darden Restaurants, Deere, Lam Research, Oracle, Palo Alto Networks and Zoom Video Communications.
Friday’s top analyst upgrades and downgrades included BP, Cloudflare, Expedia, FireEye, Marathon Oil, Moderna, Pinduoduo, Vertex Pharmaceuticals and ViacomCBS.
24/7 Wall St. has compiled a list of some speculative biotech plays that could see gains of up to 300% in the coming months.
Friday's top analyst upgrades and downgrades included Alteryx, Booking, CarGurus, Datadog, FedEx, First Solar, Uber Technologies, Vonage, Yeti and Zillow.
Dynavax Technologies shares made a handy gain on Thursday after the company announced that it would be entering the coronavirus vaccine business. Is the market for these vaccines getting oversaturated?
The top analyst upgrades, downgrades and other research calls from Thursday include Andeavor, Cimarex Energy, Groupon, Macy's, Marathon Petroleum, Match Group and Republic Services.
Dynavax Technologies saw its shares make a handy gain early on Wednesday after the company announced that it received a recommendation from the CDC's Advisory Committee on Immunization Practices.
Chris Lange The top analyst upgrades, downgrades and other research calls from Monday include Apple, BHP Billiton, CBS, Eli Lilly, GE, Halliburton, IBM, Schlumberger and Verizon.
A new RBC report is reasonably positive on the biotech sector for the coming year. These eight top picks for 2018 all have the potential for big upside moves.
These are some of the biggest biopharma stocks moving on Wednesday, as markets have hit new intraday highs, continuing to climb in the wake of the White House announcements.
24/7 Wall St. has collected several catalysts that are coming up on the calendar in the month of December.
